Skip to content
Riskpilot
← Back to search
Sign in
Get full access
inat Clinical Trials Billdal AB
AB
Active
Org 5593610974
Hedens Äng 43, 427 50
Billdal
Regulation of health care, education, cultural services and other social services
· NACE 8412
Est. 2022
1 employees
Watchlist
Share
Sweden
/
Companies
/
Regulation of health care, education, cultural services and other social services
/
inat Clinical Trials Billdal AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
508
1 169
1 062
585
Staff expenses
−51
−235
−197
−73
EBITDA
405
846
784
438
Depreciation & amort.
—
—
—
—
EBIT
405
846
784
438
Net financials
−0
0
34
31
Profit before tax
305
636
618
349
Tax
−64
−135
−131
−75
Net profit
242
502
487
273
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
518
1 220
1 694
1 734
Equity
267
588
876
949
Long-term debt
—
—
—
—
Short-term debt
151
322
308
155
Total debt
151
322
308
155
Financial ratios
5-year trend
EBITDA margin
74.9%
This company
15.8%
Market median
+374% vs market
2022
2025
Equity ratio
54.7%
This company
38.2%
Market median
+43% vs market
2022
2025
Return on equity
28.8%
This company
18.4%
Market median
+57% vs market
2022
2025
Net profit margin
46.7%
This company
8.1%
Market median
+477% vs market
2022
2025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
2022
2025
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-18 – 2022-12-31
View
PDF
More on inat Clinical Trials Billdal AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
